Skip to main content
B

BioOrbit

BioOrbit develops hardware for protein crystallization in space, enabling the production of higher-quality protein crystals for pharmaceutical drug development. This allows for the creation of more effective and stable protein-based drugs.

Founded 2023132K+ followers
Updated 16 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

The crystallization of protein drugs on Earth is hindered by sedimentation and convection currents, leading to imperfect crystals with a broad size distribution. These imperfections can reduce the efficacy and stability of protein-based pharmaceuticals, limiting the potential for subcutaneous administration and home-based care.

Solution

BioOrbit is developing hardware for protein crystallization in microgravity, enabling the production of highly uniform, high-quality protein crystals for pharmaceutical applications. By leveraging the absence of sedimentation and convection in space, BioOrbit's platform facilitates the creation of more perfect crystals with a smaller size distribution, improving drug efficacy and stability. This technology supports the shift from intravenous to subcutaneous injection, enabling self-administration and reducing the burden on hospitals. BioOrbit aims to be a leading provider of space-based pharmaceutical manufacturing, offering pharmaceutical companies and researchers the opportunity to enhance their protein drug products through microgravity crystallization.

Target Audience

BioOrbit's primary customers are pharmaceutical companies and research institutions focused on developing and improving protein-based drugs.

Features

  • Hardware platform for protein drug crystallization in microgravity environments
  • Technology designed to produce highly uniform crystals with a narrow size distribution
  • Facilitates the development of protein drugs suitable for subcutaneous administration
  • Supports large-scale crystallization of protein drugs
  • Collaboration opportunities for pharmaceutical companies and researchers interested in microgravity crystallization
  • Payload integration into space-based reentry vehicles for sample return
This profile is AI-generated and may contain inaccuracies.